iCRT14

iCRT14

CAT N°: 22132
Price:

From 146.00 124.10

iCRT14 is a potent inhibitor of ?-catenin-responsive transcription (CRT) that inhibits Wnt signaling in a reporter assay in vitro (IC50 = 40.3 nM).{39368} It inhibits the interaction between ?-catenin and T cell factor 4 (Tcf4) in quantitative reporter assays of ?-catenin/Tcf4 binding (Ki = 53.51 ?M).{39369} It inhibits Notch, hedgehog (Hh), and JAK/STAT signaling in reporter assays with IC50 values of 69.2, 194, and 70 nM, respectively. iCRT14 (50 mg/kg, i.p.) reduces the number of proliferating cells and leads to a decrease of approximately 50% in the initial tumor growth rate in mouse xenograft models of colon carcinoma. iCRT14 also inhibits proliferation of leukemia cell lines and suppresses ATP-driven migration of the MCF-7 and MDA-MB-231 breast cancer cell lines.{39370,39371}

We also advise you